The emergence of precision urologic oncology: a collaborative review on biomarker-driven therapeutics

More about Open Access at the Crick


Biomarker-driven cancer therapy, also referred to as precision oncology, has received increasing attention for its promise of improving patient outcomes by defining subsets of patients more likely to respond to various therapies.